课题基金 / 基金详情

REGULATION AND FUNCTION OF KIBRA IN THE HIPPO SIGNALING PATHWAY

REGULATION AND FUNCTION OF KIBRA IN THE HIPPO SIGNALING PATHWAY
KIBRA 在 HIPPO 信号通路中的调节和功能
批准号:
8168390
负责人:
Jixin Dong
金额:
$27.39万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2011-06-30

项目摘要

项目成果

Jixin Dong的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 Kibra是果蝇河马信号通路的新成员。Kibra影响河马信号转导的机制以及Kibra在哺乳动物细胞中的功能尚不清楚。 我们证明Kibra与Lats1和Lats2关联并激活它们。此外,我们还发现,Kibra特异性RNAi的表达减少,Kibra的过度表达增加了作为Lats1/2激酶下游底物/靶点的磷酸化YAP的细胞水平。有趣的是,我们发现Kibra通过抑制Lats2的泛素化来稳定Lats2。Kibra延长了Lats2的半衰期。Kibra本身是河马信号通路的转录目标,在小鼠和人类细胞中都是如此。 Kibra促进Lats2上S83的磷酸化,这依赖于Aur-A激酶。过表达Kibra强烈刺激Aur-A自身磷酸化水平(p-T288)显示的Aur-A激酶活性。此外,当Aur-A和Kibra蛋白在293T细胞中共转染时,我们能够检测到两者之间的相互作用。我们发现Kibra是一种磷酸化蛋白,Kibra的磷酸化水平出现在G2/M期。Kibra的RNAi敲除破坏了微管结构,影响了Aurora-A和Lats2的定位。Kibra还控制中心体成熟和染色体比对。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. KIBRA is a new component of the Hippo signaling pathway in Drosophila. Mechanisms by which KIBRA affects Hippo signaling and the function of KIBRA in mammalian cells are not clear. We demonstrated that KIBRA associates with and activates Lats1and Lats2. In addition, we showed that transfection of RNAi specific for KIBRA decreases and over-expression of KIBRA increases the cellular level of phosphorylated YAP, which is the downstream substrate/target of the Lats1/2 kinases. Interestingly, we found that KIBRA stabilizes Lats2 by inhibiting the ubiquitylation of Lats2. KIBRA prolongs the half-life of Lats2. KIBRA itself is a transcriptional target of the Hippo signaling pathway both in mouse and human cells. KIBRA promotes phosphorylation of S83 on Lats2, which is dependent on Aur-A kinase. Over-expression of KIBRA strongly stimulates Aur-A kinase activity revealed by Aur-A auto-phosphorylation level (p-T288). Furthermore, we were able to detect the interaction between Aur-A and KIBRA when these two proteins were co-transfected in 293T cells. We found that KIBRA is a phospho-protein, the phospho-level of KIBRA peaks at the G2/M phase. RNAi-knockdown of KIBRA disrupts the microtubule structure and affects the Aurora-A and Lats2 localization. KIBRA also controls centrosome maturation and chromosome alignment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting MARK2-HDAC signaling to overcome paclitaxel resistance in pancreatic cancer
Targeting MARK2-HDAC signaling to overcome paclitaxel resistance in pancreatic cancer
Targeting PKR-Bcl2 Signaling to Overcome Paclitaxel Resistance in Ovarian Cancer
Targeting PKR-Bcl2 Signaling to Overcome Paclitaxel Resistance in Ovarian Cancer
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: